In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Option Care Health (OPCH – Research Report). The company’s shares closed yesterday at $30.59.
According to TipRanks, S Macdonald is a 5-star analyst with an average return of 12.6% and a 65.43% success rate. S Macdonald covers the Healthcare sector, focusing on stocks such as Option Care Health, Cigna, and Humana.
Currently, the analyst consensus on Option Care Health is a Strong Buy with an average price target of $38.75, which is a 26.68% upside from current levels. In a report released yesterday, Bank of America Securities also reiterated a Buy rating on the stock with a $43.00 price target.
OPCH market cap is currently $5.31B and has a P/E ratio of 20.68.
Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Option Care Health (OPCH) Company Description:
Option Care Health, Inc. provides home and alternate site infusion services. The company was founded in 1996 and is headquartered in Bannockburn, IL.
